<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122501">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01659372</url>
  </required_header>
  <id_info>
    <org_study_id>ABT-1233-RV</org_study_id>
    <nct_id>NCT01659372</nct_id>
  </id_info>
  <brief_title>Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain</brief_title>
  <official_title>Phase 1 Study of Low Level Laser Therapy Versus Naproxen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University</source>
  <oversight_info>
    <authority>Iran: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      tempromandibuar disorders are a group of heterogenous pathologies affecting
      temporomandibular joint,muscles or both.in more than 90%of cases muscles are the origin of
      pain.TMDs cause pain,movement disability and deficit in quality of life.in more than 90%of
      cases pain is the major complaint.we run this investigation to find the analgesic effct of
      low level laser therapy versus pharmacotherapy with naproxen in improving pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>reduction of paim measured by VAS</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>VAS is visual analogue scale</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>TMD</condition>
  <arm_group>
    <arm_group_label>Low level laser therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this arm recieves low level laser therapy treatment for 12 sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>naproxen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>this arm takes naproxen 500 mg twice daily for 3weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>low level laser therapy</intervention_name>
    <arm_group_label>Low level laser therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naproxen</intervention_name>
    <arm_group_label>naproxen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with TMD affecting masticatory muscles

        Exclusion Criteria:

          -  systemic disease

          -  GI problem

          -  pregnancy

          -  epidermal cancer
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>saranaz azari marhabi, post graduate student</last_name>
    <phone>00989190129151</phone>
    <email>saranazazari@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shahid Beheshti University</name>
      <address>
        <city>Tehran</city>
        <zip>1983969411</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shahid Beheshti University</name>
      <address>
        <city>Tehran</city>
        <zip>1983969411</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>saranaz azari-marhabi, doctor</last_name>
      <phone>00989190129151</phone>
      <email>saranazazari@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>saranaz azari-marhabi, resident</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 6, 2012</lastchanged_date>
  <firstreceived_date>August 4, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University</investigator_affiliation>
    <investigator_full_name>saranaz azari-marhabi</investigator_full_name>
    <investigator_title>oral medicine resident</investigator_title>
  </responsible_party>
  <keyword>temporomandibular disorder</keyword>
  <keyword>myofascial pain syndrome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Naproxen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
